Clinical Trial Update: Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on mesenchymal stem cell therapy for Type 1 Diabetes Mellitus in Phase 1/Phase 2, with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Van Hanh General Hospital | Conditions: Type 1 Diabetes Mellitus | Phase 1, Phase 2 | Status: UNKNOWN